Literature DB >> 9810976

Epicanthoplasty with modified Y-V advancement procedure.

Y S Kao1, C H Lin, R H Fang.   

Abstract

The presence of epicanthal folds and lack of supratarsal folds are unique features in most Asian eyelids. Although many surgical procedures are available to eliminate epicanthal folds, scarring on the medial canthus is still an obstacle for surgeons to overcome. From January of 1989 to November of 1997, we used modified Y-V advancement procedures in 148 cases to correct epicanthal folds in Asian eyelids. Five of those cases involved congenital palpebral anomalies, including congenital entropion, congenital ptosis, and Down syndrome. There were few complications in our series. We believe that the modified Y-V advancement procedure causes minimum scarring on medial canthus in correcting Oriental epicanthal folds and congenital palpebral anomalies. This procedure can also be simultaneously combined with blepharoplasties and corrective procedures of eyelids.

Entities:  

Mesh:

Year:  1998        PMID: 9810976     DOI: 10.1097/00006534-199811000-00004

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  4 in total

1.  Asian blepharoplasty.

Authors:  Marilyn Q Nguyen; Patrick W Hsu; Tue A Dinh
Journal:  Semin Plast Surg       Date:  2009-08       Impact factor: 2.314

2.  Reconsideration of the Epicanthus: Evolution of the Eyelid and the Devolutional Concept of Asian Blepharoplasty.

Authors:  Bongsik Kwon; Anh H Nguyen
Journal:  Semin Plast Surg       Date:  2015-08       Impact factor: 2.314

3.  Fish-tail resection for treating congenital entropion in Asians.

Authors:  Kazuaki Nakauchi; Osamu Mimura
Journal:  Clin Ophthalmol       Date:  2012-05-31

4.  Restoration of Complicated Epicanthus: Modified Reverse Skin Redraping With Mini-epicanthoplasty for Rescue in Unsatisfied Epicanthoplasty Patients.

Authors:  Yoon Jae Chung; Kyung Eun Han; Bo Young Park
Journal:  Ann Plast Surg       Date:  2017-06       Impact factor: 1.539

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.